FDA warning letter
Issue date
26 Oct 2023
Issuing office
Division of Pharmaceutical Quality Operations III
Posted date
21 Nov 2023
Subject
CGMP/Finished Pharmaceuticals/Adulterated
Products & Services
Drugs
Issue date
Issuing office
Posted date
Subject
Products & Services